{
    "paper_id": "5f046172b4331762c75f09de0efedcccac9fc80d",
    "metadata": {
        "title": "488 Acetaminophen, 99-100, 100f, 446 Achlorhydria, 338 a 1 -acid glycoprotein (AAG), 394 Actimid, 342 Action items, 168 Active metabolites",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Cyclooxygenase-1 (COX1), 21, 285 Cyclooxygenase-2 (COX2), 21, 285, 331 Cyclosporin A, 187, 194, [208] [209] 251, 341 Cystic fibrosis (CF), 86-87 Cystic fibrosis transmembrane receptor, 87 Cytochrome P450 (CYP), 90, 365-66, 448f, 1A2, 442-43, 445, 447-48 3A4, 44-5, 98, 265, 272, 376, 387-88, 415, 437, 439, 446-47 2A6, 375f 2C8, 375f 2C9, 385, 430-32, 440, 445 2C19, 92-3, 103, 430-31 2D6, 90-2, 103, 430-31, 435, 444-45 2E1, 98 Fomivirsen, 190 Food effects, 147 Forest Labs, 22, 371, 435 Formularies, tiered, 63, 103 Formulatability, 145 Formulation, 472, solution, 414 suspension, 337, 187, 376 Natural products, 235, 46 Nelfinavir, 299, 304, 404 Neutropenia, 197 Nevirapine, 300 New Chemical Entity (NCE) Notebooks, laboratory, 122, 144 Novartis, 24, 32, 97, 322, 364 Novel targets, 142, 175, [209] [210] 265 Nucleases, 190, 101, 123 Odanacatib, 327 Offshoring, see Outsourcing, global Olanzapine, 242, 379 Omeprazole, 415 Omics, 42, 184 Omnitrope, 25 Oncology, 60, 104, 135, 203 343, 347, 366, 376, 415 Peptides, 6, 13, 303, 335, 369, 372, 415 Peptidoglycan transpeptidase, bacterial, 285 Peptidomimetics, 347, 415 Performance: evaluations, 325 levels, 85, 483 metrics for researchers, 159, 482 Perkin,William, 2 Perlegen Sciences, 96 Peroxisome proliferator-activated receptor gamma (PPAR), 177, 181, 88, [102] [103] [104] 194, 209, 211 Pfizer Inc., 9, 46, Michael, 12, 26, 33, 65 Vertex Pharmaceuticals, [10] [11] 165, 199, 230, 250, 307, 490 Vertical integration, ",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 61,
                    "text": "21,",
                    "ref_id": null
                },
                {
                    "start": 62,
                    "end": 66,
                    "text": "285,",
                    "ref_id": null
                },
                {
                    "start": 67,
                    "end": 85,
                    "text": "331 Cyclosporin A,",
                    "ref_id": null
                },
                {
                    "start": 86,
                    "end": 90,
                    "text": "187,",
                    "ref_id": null
                },
                {
                    "start": 91,
                    "end": 95,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 96,
                    "end": 101,
                    "text": "[208]",
                    "ref_id": null
                },
                {
                    "start": 102,
                    "end": 107,
                    "text": "[209]",
                    "ref_id": null
                },
                {
                    "start": 108,
                    "end": 112,
                    "text": "251,",
                    "ref_id": null
                },
                {
                    "start": 113,
                    "end": 116,
                    "text": "341",
                    "ref_id": null
                },
                {
                    "start": 211,
                    "end": 428,
                    "text": "90, 365-66, 448f, 1A2, 442-43, 445, 447-48 3A4, 44-5, 98, 265, 272, 376, 387-88, 415, 437, 439, 446-47 2A6, 375f 2C8, 375f 2C9, 385, 430-32, 440, 445 2C19, 92-3, 103, 430-31 2D6, 90-2, 103, 430-31, 435, 444-45 2E1, 98",
                    "ref_id": null
                },
                {
                    "start": 429,
                    "end": 440,
                    "text": "Fomivirsen,",
                    "ref_id": null
                },
                {
                    "start": 441,
                    "end": 458,
                    "text": "190 Food effects,",
                    "ref_id": null
                },
                {
                    "start": 459,
                    "end": 475,
                    "text": "147 Forest Labs,",
                    "ref_id": null
                },
                {
                    "start": 476,
                    "end": 479,
                    "text": "22,",
                    "ref_id": null
                },
                {
                    "start": 480,
                    "end": 484,
                    "text": "371,",
                    "ref_id": null
                },
                {
                    "start": 485,
                    "end": 501,
                    "text": "435 Formularies,",
                    "ref_id": null
                },
                {
                    "start": 502,
                    "end": 509,
                    "text": "tiered,",
                    "ref_id": null
                },
                {
                    "start": 510,
                    "end": 513,
                    "text": "63,",
                    "ref_id": null
                },
                {
                    "start": 514,
                    "end": 534,
                    "text": "103 Formulatability,",
                    "ref_id": null
                },
                {
                    "start": 535,
                    "end": 551,
                    "text": "145 Formulation,",
                    "ref_id": null
                },
                {
                    "start": 552,
                    "end": 556,
                    "text": "472,",
                    "ref_id": null
                },
                {
                    "start": 557,
                    "end": 566,
                    "text": "solution,",
                    "ref_id": null
                },
                {
                    "start": 567,
                    "end": 582,
                    "text": "414 suspension,",
                    "ref_id": null
                },
                {
                    "start": 583,
                    "end": 587,
                    "text": "337,",
                    "ref_id": null
                },
                {
                    "start": 588,
                    "end": 592,
                    "text": "187,",
                    "ref_id": null
                },
                {
                    "start": 593,
                    "end": 614,
                    "text": "376 Natural products,",
                    "ref_id": null
                },
                {
                    "start": 615,
                    "end": 619,
                    "text": "235,",
                    "ref_id": null
                },
                {
                    "start": 620,
                    "end": 634,
                    "text": "46 Nelfinavir,",
                    "ref_id": null
                },
                {
                    "start": 635,
                    "end": 639,
                    "text": "299,",
                    "ref_id": null
                },
                {
                    "start": 640,
                    "end": 644,
                    "text": "304,",
                    "ref_id": null
                },
                {
                    "start": 645,
                    "end": 661,
                    "text": "404 Neutropenia,",
                    "ref_id": null
                },
                {
                    "start": 662,
                    "end": 677,
                    "text": "197 Nevirapine,",
                    "ref_id": null
                },
                {
                    "start": 678,
                    "end": 707,
                    "text": "300 New Chemical Entity (NCE)",
                    "ref_id": null
                },
                {
                    "start": 708,
                    "end": 718,
                    "text": "Notebooks,",
                    "ref_id": null
                },
                {
                    "start": 719,
                    "end": 730,
                    "text": "laboratory,",
                    "ref_id": null
                },
                {
                    "start": 731,
                    "end": 735,
                    "text": "122,",
                    "ref_id": null
                },
                {
                    "start": 736,
                    "end": 749,
                    "text": "144 Novartis,",
                    "ref_id": null
                },
                {
                    "start": 750,
                    "end": 753,
                    "text": "24,",
                    "ref_id": null
                },
                {
                    "start": 754,
                    "end": 757,
                    "text": "32,",
                    "ref_id": null
                },
                {
                    "start": 758,
                    "end": 761,
                    "text": "97,",
                    "ref_id": null
                },
                {
                    "start": 762,
                    "end": 766,
                    "text": "322,",
                    "ref_id": null
                },
                {
                    "start": 767,
                    "end": 785,
                    "text": "364 Novel targets,",
                    "ref_id": null
                },
                {
                    "start": 786,
                    "end": 790,
                    "text": "142,",
                    "ref_id": null
                },
                {
                    "start": 791,
                    "end": 795,
                    "text": "175,",
                    "ref_id": null
                },
                {
                    "start": 796,
                    "end": 801,
                    "text": "[209]",
                    "ref_id": null
                },
                {
                    "start": 802,
                    "end": 807,
                    "text": "[210]",
                    "ref_id": null
                },
                {
                    "start": 808,
                    "end": 822,
                    "text": "265 Nucleases,",
                    "ref_id": null
                },
                {
                    "start": 823,
                    "end": 827,
                    "text": "190,",
                    "ref_id": null
                },
                {
                    "start": 828,
                    "end": 832,
                    "text": "101,",
                    "ref_id": null
                },
                {
                    "start": 833,
                    "end": 848,
                    "text": "123 Odanacatib,",
                    "ref_id": null
                },
                {
                    "start": 849,
                    "end": 864,
                    "text": "327 Offshoring,",
                    "ref_id": null
                },
                {
                    "start": 865,
                    "end": 881,
                    "text": "see Outsourcing,",
                    "ref_id": null
                },
                {
                    "start": 882,
                    "end": 900,
                    "text": "global Olanzapine,",
                    "ref_id": null
                },
                {
                    "start": 901,
                    "end": 905,
                    "text": "242,",
                    "ref_id": null
                },
                {
                    "start": 906,
                    "end": 921,
                    "text": "379 Omeprazole,",
                    "ref_id": null
                },
                {
                    "start": 922,
                    "end": 932,
                    "text": "415 Omics,",
                    "ref_id": null
                },
                {
                    "start": 933,
                    "end": 936,
                    "text": "42,",
                    "ref_id": null
                },
                {
                    "start": 937,
                    "end": 951,
                    "text": "184 Omnitrope,",
                    "ref_id": null
                },
                {
                    "start": 952,
                    "end": 964,
                    "text": "25 Oncology,",
                    "ref_id": null
                },
                {
                    "start": 965,
                    "end": 968,
                    "text": "60,",
                    "ref_id": null
                },
                {
                    "start": 969,
                    "end": 973,
                    "text": "104,",
                    "ref_id": null
                },
                {
                    "start": 974,
                    "end": 978,
                    "text": "135,",
                    "ref_id": null
                },
                {
                    "start": 979,
                    "end": 982,
                    "text": "203",
                    "ref_id": null
                },
                {
                    "start": 983,
                    "end": 987,
                    "text": "343,",
                    "ref_id": null
                },
                {
                    "start": 988,
                    "end": 992,
                    "text": "347,",
                    "ref_id": null
                },
                {
                    "start": 993,
                    "end": 997,
                    "text": "366,",
                    "ref_id": null
                },
                {
                    "start": 998,
                    "end": 1002,
                    "text": "376,",
                    "ref_id": null
                },
                {
                    "start": 1003,
                    "end": 1016,
                    "text": "415 Peptides,",
                    "ref_id": null
                },
                {
                    "start": 1017,
                    "end": 1019,
                    "text": "6,",
                    "ref_id": null
                },
                {
                    "start": 1020,
                    "end": 1023,
                    "text": "13,",
                    "ref_id": null
                },
                {
                    "start": 1024,
                    "end": 1028,
                    "text": "303,",
                    "ref_id": null
                },
                {
                    "start": 1029,
                    "end": 1033,
                    "text": "335,",
                    "ref_id": null
                },
                {
                    "start": 1034,
                    "end": 1038,
                    "text": "369,",
                    "ref_id": null
                },
                {
                    "start": 1039,
                    "end": 1043,
                    "text": "372,",
                    "ref_id": null
                },
                {
                    "start": 1044,
                    "end": 1077,
                    "text": "415 Peptidoglycan transpeptidase,",
                    "ref_id": null
                },
                {
                    "start": 1078,
                    "end": 1088,
                    "text": "bacterial,",
                    "ref_id": null
                },
                {
                    "start": 1089,
                    "end": 1109,
                    "text": "285 Peptidomimetics,",
                    "ref_id": null
                },
                {
                    "start": 1110,
                    "end": 1114,
                    "text": "347,",
                    "ref_id": null
                },
                {
                    "start": 1115,
                    "end": 1131,
                    "text": "415 Performance:",
                    "ref_id": null
                },
                {
                    "start": 1296,
                    "end": 1300,
                    "text": "177,",
                    "ref_id": null
                },
                {
                    "start": 1301,
                    "end": 1305,
                    "text": "181,",
                    "ref_id": null
                },
                {
                    "start": 1306,
                    "end": 1309,
                    "text": "88,",
                    "ref_id": null
                },
                {
                    "start": 1310,
                    "end": 1315,
                    "text": "[102]",
                    "ref_id": null
                },
                {
                    "start": 1316,
                    "end": 1321,
                    "text": "[103]",
                    "ref_id": null
                },
                {
                    "start": 1322,
                    "end": 1327,
                    "text": "[104]",
                    "ref_id": null
                },
                {
                    "start": 1328,
                    "end": 1332,
                    "text": "194,",
                    "ref_id": null
                },
                {
                    "start": 1333,
                    "end": 1337,
                    "text": "209,",
                    "ref_id": null
                },
                {
                    "start": 1338,
                    "end": 1354,
                    "text": "211 Pfizer Inc.,",
                    "ref_id": null
                },
                {
                    "start": 1355,
                    "end": 1357,
                    "text": "9,",
                    "ref_id": null
                },
                {
                    "start": 1358,
                    "end": 1361,
                    "text": "46,",
                    "ref_id": null
                },
                {
                    "start": 1362,
                    "end": 1370,
                    "text": "Michael,",
                    "ref_id": null
                },
                {
                    "start": 1371,
                    "end": 1374,
                    "text": "12,",
                    "ref_id": null
                },
                {
                    "start": 1375,
                    "end": 1378,
                    "text": "26,",
                    "ref_id": null
                },
                {
                    "start": 1379,
                    "end": 1382,
                    "text": "33,",
                    "ref_id": null
                },
                {
                    "start": 1383,
                    "end": 1409,
                    "text": "65 Vertex Pharmaceuticals,",
                    "ref_id": null
                },
                {
                    "start": 1410,
                    "end": 1414,
                    "text": "[10]",
                    "ref_id": null
                },
                {
                    "start": 1415,
                    "end": 1419,
                    "text": "[11]",
                    "ref_id": null
                },
                {
                    "start": 1420,
                    "end": 1424,
                    "text": "165,",
                    "ref_id": null
                },
                {
                    "start": 1425,
                    "end": 1429,
                    "text": "199,",
                    "ref_id": null
                },
                {
                    "start": 1430,
                    "end": 1434,
                    "text": "230,",
                    "ref_id": null
                },
                {
                    "start": 1435,
                    "end": 1439,
                    "text": "250,",
                    "ref_id": null
                },
                {
                    "start": 1440,
                    "end": 1444,
                    "text": "307,",
                    "ref_id": null
                },
                {
                    "start": 1445,
                    "end": 1470,
                    "text": "490 Vertical integration,",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "acute respiratory syndrome (SARS), 198 Shadow pricing, 22 SHAPES",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Shelf life, library",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Short hairpin RNA (shRNA)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Side effects",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "46",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Simulated gastric fluid (SGF)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "335",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Simulated intestinal fluid (SIF)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "335",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Single chain Fv fragments (scFvs)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Single nucleotide polymorphism (SNP)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "85--91",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Single nucleotide polymorphism, synonymous",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "86",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Size, problems of corporate, 58, 478 Slow off-rate compounds",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "286--87",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Small interfering RNA (siRNA), 191-92 Solid phase extraction (SPE)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "313, 413, kinetic, 335-36 minimum suggested, for drugs, 337 predicted, 413 thermodynamic",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Solubility",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Somatotropin (hGH), see Omnitrope Spana, Carl, 30 Specialty pharmaceuticals, 60 Species specificity",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Spinout companies",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "73--77",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "405 Stability: chemical, 340-41, 371 gastrointestinal tract, 374f metabolic",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "St",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "John&apos;s Wort",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "98",
            "issn": "",
            "pages": "383--84",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Standard Cooperative R&D Agreement (standard CRADA)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "137--175",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Structural novelty",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "262",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Structure-activity relationship (SAR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "124",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Structure-based drug design (SBDD)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "297",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Structure-based ligand design, see Structurebased drug design (SBDD) Sudden cardiac death (SCD)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Summary of the invention",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "127",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Surface plasmon resonance (SPR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "189",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Syndrome X, see Metabolic syndrome Syndrome, Fragile X",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Syngeneic models",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Syntex Corporation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Synthetic tractability",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF1": {
            "text": "see Azathioprine In vitro in vivo extrapolation (IVIVE), 385 In vitro micronucleus assay (IVMN), 387 Inactivators, mechanism-based, 285-86, 433 Incubators, 74-5, 105 Incyte Corporation, 11 Indels, see Insertions and deletions",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Thiazolidinediones, see Glitazones Thiopurine methyltransferase (TPMT), 93 Three hybrid systems, 208 Tipranavir, 333 TNFa, see Tumor necrosis factor alpha Tofranil, see Imipramine Tool compounds, 136-37, 199, 267, 286 Topoisomerase I, 347 Topoisomerase II, see DNA gyrase Topotecan, 346 Torsade de pointe (TdP) arrhythmia, Tumor necrosis factor alpha, 182-83, 482-83 Two boss syndrome, 157-58 Tysabri, see Natalizumab U.S. Patent and Trademark Office (PTO), 11, Valium, see Diazepam Valsartan, 329, 375, 380-82 Valtrex, see Valacyclovir Vardenafil, 330-31 Varney, Michael, 472 Veber, Daniel, 359 Vectibix, see Panitumumab Velcade, see Bortezomib Venlafaxine, 439 Venter, J. Craig, 10 Venture capital (VC), 69 Venuti,",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Vitravene, see Fomivirsen Voltaren, see Diclofenac Volume of distribution (V d ), 411-12 von Hoffmann, August Wilhelm, 2 Warfarin, see Coumadin Warner-Lambert Pharmaceutical Company, 72, 180, 336 Washington University, St. Louis, 101 Watson, James, 9-10 Wertheimer, Albert, 33, 57, 62, 178 Whole genome association studies, 87 Whole genome shotgun sequencing (WGS), 10 Woodcock, Janet, 21 Working examples, 128 World Trade Organization (WTO), 36 WuXi Pharmatech, 32 Wyeth Pharmaceuticals, 348, 435",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": " Sandoz, 24 Sanger, Frederick, 9, 28 Saquinavir, 249, 253 Scaffold: hopping, 265, 328, 391 Schizophrenia, 87, 262, 441 Schreiber, Stuart, 68, 207 ",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 8,
                    "text": "Sandoz,",
                    "ref_id": null
                },
                {
                    "start": 9,
                    "end": 19,
                    "text": "24 Sanger,",
                    "ref_id": null
                },
                {
                    "start": 20,
                    "end": 30,
                    "text": "Frederick,",
                    "ref_id": null
                },
                {
                    "start": 31,
                    "end": 33,
                    "text": "9,",
                    "ref_id": null
                },
                {
                    "start": 34,
                    "end": 48,
                    "text": "28 Saquinavir,",
                    "ref_id": null
                },
                {
                    "start": 49,
                    "end": 53,
                    "text": "249,",
                    "ref_id": null
                },
                {
                    "start": 54,
                    "end": 76,
                    "text": "253 Scaffold: hopping,",
                    "ref_id": null
                },
                {
                    "start": 77,
                    "end": 81,
                    "text": "265,",
                    "ref_id": null
                },
                {
                    "start": 82,
                    "end": 86,
                    "text": "328,",
                    "ref_id": null
                },
                {
                    "start": 87,
                    "end": 105,
                    "text": "391 Schizophrenia,",
                    "ref_id": null
                },
                {
                    "start": 106,
                    "end": 109,
                    "text": "87,",
                    "ref_id": null
                },
                {
                    "start": 110,
                    "end": 114,
                    "text": "262,",
                    "ref_id": null
                },
                {
                    "start": 115,
                    "end": 129,
                    "text": "441 Schreiber,",
                    "ref_id": null
                },
                {
                    "start": 130,
                    "end": 137,
                    "text": "Stuart,",
                    "ref_id": null
                },
                {
                    "start": 138,
                    "end": 141,
                    "text": "68,",
                    "ref_id": null
                },
                {
                    "start": 142,
                    "end": 145,
                    "text": "207",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}